Sleep

A new study found sleep and emotional well-being are impacted days before women get their period.

The SYMPHONY trial found reboxetine can significantly reduce cataplexy, excessive daytime sleepiness, cognitive impairment, depression, and anxiety for patients with narcolepsy.

With limited CBTi-trained psychologists, investigators assessed the effectiveness of a self-guided digital CBTi as another option, so people don’t have to turn to pills.

More than half of the participants were identified as insomnia sleepers and nappers, two suboptimal sleep patterns linked with an increased risk of a chronic condition.

After 5 years, laparoscopic Roux-en-Y gastric bypass cured OSA in 55.1% of patients, and only 20% of patients still had moderate or severe OSA.

Now, 4 years since the start of the pandemic, how has sleep been impacted? Sleep experts provide their perspective.

FDA issued a Complete Response Letter to Vanda Pharmaceuticals stating tasimelteon for treating insomnia cannot be approved in its current form due to identified deficiencies.

Results of a new analysis underscore the significance of sleep health in mitigating type 2 diabetes risk, revealing that even an optimal diet may not fully offset the negative impact of inadequate sleep.

Our February 2024 month-in-review recaps research on Long COVID’s effect on sleep, Black older adults’ poor sleep quality being linked to executive function decline, among other findings.

In time for daylight savings time starting on March 10, sleep experts weigh in on the harms of the daylight savings transition, such as increased risks for cardiovascular events, car accidents, and mortality.

In the final part of our 3-part series, our panel of experts discuss what their fields and its leaders could do to make sure this lack of diversity in trials does not continue. These responses are highlighted in the following video and transcribed below.

In part 2 of our 3-part series on the impact of clinical trials lacking diversity, we are spotlighting responses to our second question, which addresses how the previously established lack of diversity in clinical trials has had a direct effect on the development and application of new therapies or devices in real-world settings.

In part 1 of our 3-part series on the impact of clinical trials lacking diversity, we are spotlighting responses to our first question, which sought to encapsulate the perspectives of our group of experts on how a historic lack of diversity in clinical trials has manifested itself in today’s care of patients from diverse backgrounds.

This article serves as a landing page for our 3-part series spotlighting how a lack of diversity in clinical trials has had a deleterious downstream effect on real-world care for people of color in the US, with perspective from experts across more than half a dozen specialties.

Cancer patients with behavioral health disorders, such as substance abuse, eating disorders, and sleep disorders have a 7.76% increase in health care costs, a new study found.

A new study found only 15% of people sleep the recommended 7 – 9 hours for ≥ 5 nights per week.

Patients with both psoriasis and psoriatic arthritis may be more likely to be tired based on symptom severity.

After observing for sex differences, plant-based diet indices were associated with lower odds of OSA risk in males than females.

A new study found a greater sleep apnea risk was linked to verbal episodic memory decline and worse sleep quality was linked to executive function decline.

A new study found patients with Parkinson’s disease have a lower daytime light exposure with a mean light intensity of 201.1 lux than controls with a light intensity of 337.7 lux.

A new study found the odds of gout were 2.65 times greater in patients with OSA than in patients without OSA.

A new study for women with ≥ 4 hours a day of sedentary behavior had an increased risk of OSA but not for women with < 4 hours of sedentary behavior.

A new study found non-hospitalized COVID-19 survivors from a Vietnam general population had a 76.1% prevalence of insomnia, with 22.8% of respondents with insomnia scoring for severe insomnia.

A new study found the Healthy Patterns Sleep Program—where people have timed activities aligning with circadian rhythms—improves the quality of life after 4 weeks for individuals with cognitive impairment.

Sleep apnea prevalence in cardiology patients was similar to the rates in patients with heart failure., and sleep apnea prevalence in cardio-oncology patients was the same or greater than other traditional risk factors.

Patients with fibromyalgia have poorer accuracy for divided attention, mediated by sleep disturbance, according to a new study.

Multivariable analyses found genetic predispositions to overall rheumatoid arthritis with decreased sleep duration, as well as a significant genetic association between seropositive rheumatoid arthritis and insomnia symptoms.

After a study assessed how sleep was hindered following incidences where the police killed unarmed Black individuals, Black respondents had shorter sleep durations and more very short sleep (< 6 hours) than White participants.

Our January 2024 sleep month in review includes studies regarding periodic limb movements to link to cardiovascular disease and death, sleep apnea serving as a risk factor for uncontrolled, severe asthma, and more.

A new study found the periodic limb movement index, but not the apnea-hypopnea index, was linked to an increased risk of incident cardiovascular disease or death every 10 events per hour.